Medical News

RSS

CEL-SCI gets approval to start enrollment for Multikine Phase III study for head and neck cancer

Further advancing one of the largest Phase III trials for head and neck cancer in the world, CEL-SCI Corporation announced today that it has received approval from the Agency for Medicaments and Medical Devices of the government of Bosnia and Herzegovina to begin enrollment of subjects into the Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine (Leukocyte Interleukin, Injection).

5 Dec 2013

Presence Health uses automated IVR calls to increase colorectal cancer screening rates

Presence Health, the largest Catholic health system based in Illinois, significantly increased screening rates for colorectal cancer by utilizing automated, interactive voice response calls, according to research being presented on Dec. 10 at the Institute for Healthcare Improvement's 25th Annual National Forum on Quality Improvement in Health Care.

5 Dec 2013

AtheroNova completes active treatment portion of Phase 1 clinical trial with AHRO-001

AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the completion of the active treatment portion of its Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study objective is to evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.

5 Dec 2013

Widely varying drug costs in new health plans

The Wall Street Journal explores out-of-pocket drug costs in plans offered on the health law's exchanges. Other stories probe so called "aggregation rules" that could affect some small businesses and the law's potential impact on safety-net hospitals and clinics.

5 Dec 2013

Ventana now offers FDA-cleared image analysis and digital read application for IHC breast markers

Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration for the Companion Algorithm ER (SP1) image analysis algorithm used with the VENTANA iScan Coreo scanner running Virtuoso software. With this clearance, Ventana is now the only company in the industry offering a comprehensive portfolio of FDA-cleared image analysis algorithms and digital read applications for the five key immunohistochemistry breast markers.

5 Dec 2013

Psychological well-being may play key role in maintenance of mental health

A study published in the current issue of Psychotherapy and Psychosomatics has examined psychological well-being in patients who have recovered from depression.

5 Dec 2013

Soligenix initiates SGX942 Phase 2 study for treatment of oral mucositis

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.

5 Dec 2013

First Edition: December 5, 2013

Today's headlines include reports about how President Barack Obama is trying to connect with young adults and urge them to sign up for health coverage.

5 Dec 2013

Mylan Pharmaceuticals introduces Cabergoline Tablets USP, 0.5 mg

Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Cabergoline Tablets USP, 0.5 mg. Cabergoline Tablets USP are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.

5 Dec 2013

First Databank starts publishing NADAC pricing file released by CMS

First Databank (FDB), the leading provider of clinical drug knowledge that helps improve medication-related decisions and patient outcomes, today announced it has begun publishing the National Average Drug Acquisition Cost (NADAC) pricing file recently released by The Centers for Medicare & Medicaid Services (CMS).

5 Dec 2013

EMA expands administration options for Hizentra

CSL Behring UK Ltd announced today that the European Medicines Agency (EMA) has expanded the administration options for Hizentra®▼, human normal immunoglobulin, SCIg, 20% liquid, to include dosing once every two weeks (fortnightly).

5 Dec 2013

"Virtual T cell" predicts how human immune system reacts to foreign substances

A platform that simulates how the body defends itself: The T cells of the immune system decide whether to trigger an immune response against foreign substances.

5 Dec 2013

Quality Management Certification awarded to Marken Singapore

Marken announced today that their Singapore biological kit-building facility has now been certified to International Standards Organization (ISO) 13485 standards for the storage and distribution of medical devices.

5 Dec 2013

Gonzalez Dental Care joins U.S. Marines to fight against poverty and illiteracy

Dr. Liliana C. Gonzalez has joined the U.S. Marines in a campaign to attack poverty and illiteracy in our society through the U.S. Marines Toys for Tots and the Toys for Tots Literacry Program.

5 Dec 2013

Researchers find correlation between biomarker and patient’s ability to respond to Imprime PGG

Biothera researchers have broadened their understanding of a biomarker that may enable doctors to predict which cancer patients will best respond to Imprime PGG®, the company's immunotherapy in Phase 3 drug development for colorectal cancer.

5 Dec 2013

Type 2 diabetes management: an interview with Professor Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim

The rate of Type 2 Diabetes is rapidly increasing, particularly in Asian countries which make up more than 60 percent of the world’s diabetes population. So it’s really important physicians feel confident managing this chronic condition in their daily clinical practice.

5 Dec 2013

All China Biotech Conference & Exhibition to be held in Nanjing on May, 2014

Jointly organized by Nanjing Pushlong Business Management Co., Ltd. and more than 10 national associations, the All China Biotech Conference & Exhibition (Biotech China) will be held in Nanjing on May 14-16, 2014, providing a platform for business and academic exchanges.

5 Dec 2013

Medicines for rare diseases may be effectively valued using multi-criteria decision analysis

A study just published by the Office of Health Economics and its collaborators demonstrates how medicines for rare disease may be effectively valued using an innovative approach -- multi-criteria decision analysis -- that can include all relevant stakeholders, including patients' groups.

5 Dec 2013

Alvotech to invests $250M in the development of biosimilar monoclonal antibodies

Alvotech, a powerful new player in the field of biopharmaceuticals, today announced plans to invest $250 million in the development and manufacturing of a portfolio of biosimilar monoclonal antibodies.

5 Dec 2013

Brain anatomy affects cognitive control in children

The anatomy of the brain affects cognitive control, an essential skill for learning and academic success. This is the result of studies performed by the Laboratoire de Psychologie du Développement et de l'Education de l'Enfant (CNRS/Université Paris Descartes/Université de Caen Basse-Normandie), in collaboration with the NeuroSpin Center (CEA).

5 Dec 2013

Medical News

CEL-SCI gets approval to start enrollment for Multikine Phase III study for head and neck cancer

Presence Health uses automated IVR calls to increase colorectal cancer screening rates

AtheroNova completes active treatment portion of Phase 1 clinical trial with AHRO-001

Widely varying drug costs in new health plans

Ventana now offers FDA-cleared image analysis and digital read application for IHC breast markers

Psychological well-being may play key role in maintenance of mental health

Soligenix initiates SGX942 Phase 2 study for treatment of oral mucositis

First Edition: December 5, 2013

Mylan Pharmaceuticals introduces Cabergoline Tablets USP, 0.5 mg

First Databank starts publishing NADAC pricing file released by CMS

EMA expands administration options for Hizentra

"Virtual T cell" predicts how human immune system reacts to foreign substances

Quality Management Certification awarded to Marken Singapore

Gonzalez Dental Care joins U.S. Marines to fight against poverty and illiteracy

Researchers find correlation between biomarker and patient’s ability to respond to Imprime PGG

Type 2 diabetes management: an interview with Professor Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim

All China Biotech Conference & Exhibition to be held in Nanjing on May, 2014

Medicines for rare diseases may be effectively valued using multi-criteria decision analysis

Alvotech to invests $250M in the development of biosimilar monoclonal antibodies

Brain anatomy affects cognitive control in children

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News